London-based GHO Capital and Singapore-based CBC Group plan to merge in a deal that would create what the firms describe as the “world’s largest dedicated healthcare investment firm.” GHO has $10.5 billion assets under management, and CBC has $10.8 billion in assets under management. The post GHO Capital, CBC Group Combine to Form $21B Healthcare…
With the global market for anti-obesity drugs projected to hit $95 billion by 2030, it’s no surprise that compounded semaglutide is gaining traction as a cheaper, more accessible option. But for all its appeal, this route comes with real risks: regulatory uncertainty, legal exposure, and major insurance hurdles. The post Protecting Your Biotech: Understanding the Risks…
The OIG has released a review of the VHA’s staffing shortages for 2025
Ami Parekh is the Chief Health Officer & Ankoor Shah, is VP, Clinical Excellence at Included Health. I had a long conversation with them about the philosophy of how we are doing population health and how we fix the system that we have today. I’m arguing for more primary care, but Ami restated it and…
[Sponsored] In an interview, Abarca Chief Information Officer Serge Perras discussed how Abarca is implementing AI and where he sees the most value for PBMs. The post AI Is at the Heart of PBM Evolution appeared first on MedCity News.
This data note reviews our recent polling data that finds that Americans struggle to afford many aspects of health care, including disproportionate shares of uninsured adults, Black and Hispanic adults and those with lower incomes.
The Trump administration’s new deal lowers prices and expands access to GLP-1 drugs, but experts argue far broader reforms are needed to address high prescription drug costs overall. The post Could Trump do for Branded Expensive Drugs What He Just Did for GLP-1s? appeared first on MedCity News.
As the 2024 presidential election draws near, there are sharp differences in former President Trump’s and Vice President Harris’ records on health coverage and spending, including the Affordable Care Act, Medicaid, prescription drugs, and more. At Noon ET on Tuesday, October 1, Larry Levitt, KFF’s executive vice president for health policy, will moderate a 45-minute…More
Egg freezing has gained popularity as a fertility preservation tool, but experts say high costs, uncertain outcomes and timing challenges continue to deter many women from pursuing it. The post The 3 Biggest Roadblocks to Egg Freezing — and How Providers Are Working to Remove Them appeared first on MedCity News.
Eli Lilly reported that in addition to achieving greater reductions in weight, Zepbound-treated patients achieved greater reductions in waist circumference compared to those treated with Novo Nordisk’s Wegovy. Full details from the head-to-head Phase 3 test were presented at the European Congress on Obesity meeting. The post Details From Head-to-Head Phase 3 Test Give Fuller…